Loading organizations...
Loading organizations...
Biomedical company developing nucleic acid drugs with circular RNA technolo
Circular Code Biology has raised $20.0M across 1 funding round.
Circular Code Biology has raised $20.0M in total across 1 funding round.
Circular Code Biology has raised $20.0M in total across 1 funding round.
Circular Code Biology's investors include K2 Venture Partners, Efung Capital, Kaitai Capital.
Circular Code Biology has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Pre-Series A in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 9, 2022 | $20.0M Pre-Series A | K2 Venture Partners | Efung Capital, Kaitai Capital |